| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mast Cells | 5 | 2018 | 223 | 2.060 |
Why?
|
| Platelet Activating Factor | 3 | 2017 | 55 | 1.190 |
Why?
|
| Immunity, Innate | 3 | 2019 | 677 | 0.990 |
Why?
|
| Drug Repositioning | 1 | 2019 | 54 | 0.670 |
Why?
|
| Catalase | 1 | 2018 | 70 | 0.650 |
Why?
|
| Extracellular Traps | 1 | 2018 | 25 | 0.640 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 149 | 0.630 |
Why?
|
| Valproic Acid | 1 | 2019 | 263 | 0.610 |
Why?
|
| Tolonium Chloride | 1 | 2017 | 3 | 0.600 |
Why?
|
| DNA Damage | 6 | 2015 | 1954 | 0.580 |
Why?
|
| Histocytochemistry | 1 | 2017 | 185 | 0.570 |
Why?
|
| Antigens, Nuclear | 2 | 2013 | 119 | 0.550 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 426 | 0.470 |
Why?
|
| DNA End-Joining Repair | 2 | 2013 | 86 | 0.460 |
Why?
|
| DNA Ligases | 4 | 2013 | 63 | 0.430 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 1029 | 0.420 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 1399 | 0.420 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 575 | 0.410 |
Why?
|
| B-Lymphocytes | 3 | 2013 | 1294 | 0.390 |
Why?
|
| Radioimmunotherapy | 4 | 2024 | 119 | 0.380 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 294 | 0.340 |
Why?
|
| Homeostasis | 2 | 2013 | 950 | 0.330 |
Why?
|
| Nanoparticles | 2 | 2023 | 554 | 0.320 |
Why?
|
| Mice | 21 | 2024 | 34495 | 0.310 |
Why?
|
| Animals | 27 | 2024 | 59536 | 0.290 |
Why?
|
| Cellular Senescence | 5 | 2013 | 382 | 0.280 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 171 | 0.280 |
Why?
|
| Genes, p53 | 1 | 2011 | 1090 | 0.280 |
Why?
|
| Genes, Lethal | 1 | 2006 | 120 | 0.270 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2024 | 248 | 0.270 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 4821 | 0.270 |
Why?
|
| Immunotherapy | 7 | 2023 | 3341 | 0.260 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2017 | 528 | 0.250 |
Why?
|
| Gene Targeting | 1 | 2006 | 292 | 0.250 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2004 | 13 | 0.250 |
Why?
|
| Lymphoma, B-Cell | 1 | 2011 | 895 | 0.240 |
Why?
|
| Environmental Pollutants | 1 | 2004 | 83 | 0.230 |
Why?
|
| TNF Receptor-Associated Factor 3 | 2 | 2013 | 22 | 0.230 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2004 | 85 | 0.230 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2023 | 35 | 0.220 |
Why?
|
| Apoptosis | 5 | 2019 | 7591 | 0.220 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 741 | 0.220 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2002 | 30 | 0.220 |
Why?
|
| Activins | 1 | 2022 | 98 | 0.220 |
Why?
|
| Chick Embryo | 1 | 2002 | 242 | 0.210 |
Why?
|
| Luteinizing Hormone | 1 | 2002 | 165 | 0.210 |
Why?
|
| Caspases | 1 | 2004 | 661 | 0.200 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 241 | 0.200 |
Why?
|
| Cell Line | 4 | 2018 | 5114 | 0.200 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2023 | 406 | 0.200 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2022 | 268 | 0.200 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2023 | 1664 | 0.200 |
Why?
|
| Cell Proliferation | 5 | 2019 | 7226 | 0.190 |
Why?
|
| Cell Cycle | 3 | 2019 | 2084 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 1586 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2023 | 1146 | 0.190 |
Why?
|
| Neoplasms | 4 | 2021 | 15193 | 0.180 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 7789 | 0.180 |
Why?
|
| Lung Neoplasms | 4 | 2023 | 11538 | 0.180 |
Why?
|
| Mice, Knockout | 3 | 2017 | 5710 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2021 | 251 | 0.180 |
Why?
|
| DNA Repair | 1 | 2008 | 1872 | 0.180 |
Why?
|
| Biological Products | 1 | 2023 | 274 | 0.180 |
Why?
|
| RNA Interference | 2 | 2019 | 1408 | 0.170 |
Why?
|
| Lymphoma | 1 | 2008 | 1467 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2013 | 3552 | 0.170 |
Why?
|
| Tryptases | 1 | 2018 | 48 | 0.160 |
Why?
|
| Blood Cells | 1 | 2018 | 127 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 3578 | 0.150 |
Why?
|
| Acetylation | 2 | 2017 | 508 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2022 | 1385 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2015 | 5637 | 0.150 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2017 | 33 | 0.150 |
Why?
|
| Hematoxylin | 1 | 2017 | 34 | 0.150 |
Why?
|
| Radiation Dosage | 1 | 2021 | 1014 | 0.150 |
Why?
|
| Receptors, CXCR4 | 2 | 2017 | 269 | 0.150 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 365 | 0.140 |
Why?
|
| Ku Autoantigen | 2 | 2013 | 79 | 0.140 |
Why?
|
| Radiotherapy | 2 | 2021 | 1824 | 0.140 |
Why?
|
| DNA Ligase ATP | 4 | 2013 | 51 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 79 | 0.140 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2009 | 316 | 0.140 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 613 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 4654 | 0.140 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 83 | 0.130 |
Why?
|
| Melanoma | 2 | 2023 | 5317 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 612 | 0.130 |
Why?
|
| Hematopoiesis | 1 | 2018 | 560 | 0.130 |
Why?
|
| Photosensitizing Agents | 1 | 2015 | 71 | 0.130 |
Why?
|
| Photochemotherapy | 1 | 2015 | 96 | 0.120 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 2864 | 0.120 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2013 | 76 | 0.120 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 278 | 0.120 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 86 | 0.110 |
Why?
|
| Germinal Center | 1 | 2013 | 161 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 310 | 0.110 |
Why?
|
| Humans | 18 | 2023 | 261506 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2022 | 4078 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2018 | 548 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2013 | 220 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 154 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1121 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2013 | 576 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 430 | 0.090 |
Why?
|
| VDJ Exons | 1 | 2009 | 7 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2013 | 575 | 0.090 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2009 | 67 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 14551 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 14289 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 673 | 0.090 |
Why?
|
| Colon | 1 | 2013 | 670 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2015 | 4804 | 0.090 |
Why?
|
| beta Catenin | 1 | 2013 | 688 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2023 | 1763 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 6942 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2013 | 1038 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 810 | 0.080 |
Why?
|
| Immune Tolerance | 1 | 2010 | 403 | 0.080 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2008 | 47 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 3101 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2011 | 478 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 51 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 224 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 448 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2015 | 929 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 1538 | 0.080 |
Why?
|
| Radiation Tolerance | 1 | 2010 | 629 | 0.070 |
Why?
|
| Carcinogenesis | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2006 | 45 | 0.070 |
Why?
|
| Restriction Mapping | 1 | 2006 | 264 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2006 | 406 | 0.070 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2006 | 109 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1818 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2013 | 1549 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 3869 | 0.070 |
Why?
|
| Electroporation | 1 | 2006 | 126 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5319 | 0.070 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 185 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 1823 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 634 | 0.060 |
Why?
|
| Avian Proteins | 1 | 2004 | 27 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4557 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 2004 | 70 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 78 | 0.060 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2024 | 23 | 0.060 |
Why?
|
| Homozygote | 1 | 2006 | 717 | 0.060 |
Why?
|
| Chickens | 1 | 2004 | 523 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2004 | 122 | 0.060 |
Why?
|
| Fibronectins | 1 | 2004 | 197 | 0.060 |
Why?
|
| Proto-Oncogenes | 1 | 2024 | 202 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2004 | 189 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2004 | 171 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1960 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2007 | 3536 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2004 | 471 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 1 | 2023 | 67 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2006 | 1643 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2023 | 159 | 0.050 |
Why?
|
| Exons | 1 | 2006 | 1328 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2576 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 1399 | 0.050 |
Why?
|
| Cytokines | 1 | 2011 | 2809 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 309 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1764 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 2045 | 0.050 |
Why?
|
| Mutation | 4 | 2010 | 15179 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2022 | 374 | 0.050 |
Why?
|
| Protons | 1 | 2023 | 473 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1165 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 459 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 3203 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 1062 | 0.040 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 577 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8865 | 0.040 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2020 | 113 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 7222 | 0.040 |
Why?
|
| Stem Cells | 1 | 2006 | 1213 | 0.040 |
Why?
|
| Female | 8 | 2024 | 141928 | 0.040 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2020 | 224 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 3639 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 93 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 32848 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 470 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 1130 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2013 | 1244 | 0.040 |
Why?
|
| Macrophages | 1 | 2023 | 1304 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2022 | 1987 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2018 | 269 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 4938 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 1048 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 4143 | 0.030 |
Why?
|
| Insulin | 2 | 2013 | 1454 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 668 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2013 | 1682 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 39 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2004 | 6150 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 2013 | 130 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 191 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 7573 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 803 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 886 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 1859 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 1242 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 4367 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3719 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 370 | 0.020 |
Why?
|
| Photosensitivity Disorders | 1 | 2010 | 23 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 1489 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5112 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 1021 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2009 | 173 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 862 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 84 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 521 | 0.020 |
Why?
|
| Male | 4 | 2020 | 123000 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 229 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1489 | 0.020 |
Why?
|
| Bacteria | 1 | 2013 | 611 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 686 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 12926 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2010 | 216 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 430 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 621 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2009 | 481 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 7548 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3033 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 241 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2009 | 519 | 0.020 |
Why?
|
| Aged | 2 | 2023 | 70117 | 0.020 |
Why?
|
| Pancreas | 1 | 2009 | 718 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 568 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 1259 | 0.020 |
Why?
|
| Immune Sera | 1 | 2004 | 146 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2009 | 1234 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2004 | 108 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 1143 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1493 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2004 | 362 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 957 | 0.010 |
Why?
|
| Histones | 1 | 2009 | 1466 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2232 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 2171 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 1555 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8873 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 6295 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 1203 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 3438 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 77950 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 86204 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 11965 | 0.010 |
Why?
|